Our top pick for
Team Inc is a specialty business services business based in the US. Team shares (TISI) are listed on the NYSE and all prices are listed in US Dollars. Team employs 5,400 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$2.74|
|52-week range||$2.68 - $13.84|
|50-day moving average||$3.53|
|200-day moving average||$6.68|
|Wall St. target price||$10.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.46|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-2.84%|
|1 month (2021-09-17)||-22.38%|
|3 months (2021-07-16)||-54.33%|
|6 months (2021-04-16)||-74.93%|
|1 year (2020-10-16)||-53.24%|
|2 years (2019-10-17)||-84.74%|
|3 years (2018-10-17)||19.49|
|5 years (2016-10-17)||30.7|
Valuing Team stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Team's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Team's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $16.7 million.
The EBITDA is a measure of a Team's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$859.9 million|
|Gross profit TTM||$238.7 million|
|Return on assets TTM||-2.21%|
|Return on equity TTM||-39.15%|
|Market capitalisation||$84.9 million|
TTM: trailing 12 months
There are currently 541,318 Team shares held short by investors – that's known as Team's "short interest". This figure is 61.8% down from 1.4 million last month.
There are a few different ways that this level of interest in shorting Team shares can be evaluated.
Team's "short interest ratio" (SIR) is the quantity of Team shares currently shorted divided by the average quantity of Team shares traded daily (recently around 1.1 million). Team's SIR currently stands at 0.5. In other words for every 100,000 Team shares traded daily on the market, roughly 500 shares are currently held short.
However Team's short interest can also be evaluated against the total number of Team shares, or, against the total number of tradable Team shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Team's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Team shares in existence, roughly 20 shares are currently held short) or 0.0198% of the tradable shares (for every 100,000 tradable Team shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Team.
Find out more about how you can short Team stock.
We're not expecting Team to pay a dividend over the next 12 months.
Team's shares were split on a 2:1 basis on 29 August 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Team shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Team shares which in turn could have impacted Team's share price.
Over the last 12 months, Team's shares have ranged in value from as little as $2.68 up to $13.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Team's is 2.0238. This would suggest that Team's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Team, Inc. , together with its subsidiaries, provides asset performance assurance and optimization solutions in the United States, Canada, Europe, and internationally. It operates through three segments: Inspection and Heat Treating (IHT), Mechanical Services (MS), and Quest Integrity. The IHT segment offers non-destructive evaluation and testing, radiographic testing, ultrasonic testing, magnetic particle inspection, liquid penetrant inspection, positive material identification, electromagnetic testing, alternating current field measurement, and eddy current testing services. This segment also provides long-range guided ultrasonic testing, phased array ultrasonic testing, terminals and storage inspection and management program, rope access, mechanical and pipeline integrity, and field heat treating services. The MS segment offers engineered composite repair, emissions control/compliance, hot tapping, valve insertion, field machining, bolted joint integrity, vapor barrier plug and weld testing, and valve management services, as well as leak repair services for pipes, valves, and flanges, as well as other parts of piping systems, pipelines, and related assets. The Quest Integrity segment provides furnace tube inspection system-enabled, in-line inspection, pipeline integrity management, engineering and condition assessment, and robotics and inspection services.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.